Grossi F, Crinò L, Delmonte A, et al. Real-World Results in Non-Squamous Non-Small Cell Lung Cancer Patients: Italian Nivolumab Expanded Access Programme. 18th World Conference on Lung Cancer (WCLC) 2017, abstract MA 10.06.
Tucatinib verlengt mediane overleving met 5,5 maand in finale analyse HER2CLIMB-studie
mrt 2022 | Borstkanker